Authors:
Morse, GD
Reichman, RC
Fischl, MA
Para, M
Leedom, J
Powderly, W
Demeter, LM
Resnick, L
Bassiakos, Y
Timpone, J
Cox, S
Batts, D
Citation: Gd. Morse et al., Concentration-targeted phase I trials of atevirdine mesylate in patients with HIV infection: dosage requirements and pharmacokinetic studies, ANTIVIR RES, 45(1), 2000, pp. 47-58